Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Real-World Oral Antiviral Efficacy and COVID-19 Rebound

Hear expert insights on oral antiviral efficacy in real-world populations and COVID-19 rebound phenomenon.
Arthur Kim, MD
Released: August 5, 2022

Information on this Educational Activity

Faculty

Arthur Kim, MD

Associate Professor
Department of Medicine
Harvard Medical School
Director, Viral Hepatitis Clinic
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts

Arthur Kim, MD: drug and safety monitoring board: Kintor.

Program Medium

This program has been made available online.

Related Content

Josep M. Llibre, MD, PhD: antivirals for all adults aged 65 years and older with early COVID-19, from Clinical Care Options (CCO)

Josep M. Llibre, MD, PhD Released: September 22, 2022

Unlocked downloadable slides featuring expert insights on RSV risk, identification, and vaccines in development in older adults, from Clinical Care Options (CCO)

Dexter James Wiseman, MD Released: August 29, 2022

Brief review of clinical trial results of MVA-BN-RSV vaccine for RSV in older adults, from Clinical Care Options (CCO)

Ting Shi, PhD Released: August 18, 2022

Download slides reviewing the latest data and guidance on COVID-19 diagnosis and transmission, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: August 16, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings